Page last updated: 2024-09-03

elacridar and Hepatitis B Virus Infection

elacridar has been researched along with Hepatitis B Virus Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnoult, E; Borghys, H; De Pooter, D; Demin, S; Dhuyvetter, D; Embrechts, W; Fanning, G; Herschke, F; Khamlichi, MD; Last, S; McGowan, D; Mostmans, W; Pauwels, F; Pieters, S; Raboisson, P; Scholliers, A; Smyej, I; Stoops, B; Thoné, T; Van Schoubroeck, B; Vlach, J1

Other Studies

1 other study(ies) available for elacridar and Hepatitis B Virus Infection

ArticleYear
Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus.
    Journal of medicinal chemistry, 2016, 09-08, Volume: 59, Issue:17

    Topics: Animals; Antiviral Agents; Computer Simulation; Cytokines; Dogs; Hepatitis B; Hepatitis B virus; High-Throughput Screening Assays; Humans; Macaca fascicularis; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Pyrimidines; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Toll-Like Receptor 7; Toll-Like Receptor 8; Virus Replication

2016